Drug application
ERYGEL (ERYTHROMYCIN)
Drugs@FDA NDA 050617 · MYLAN
Key facts
| Drug name | ERYGEL |
|---|---|
| Active ingredients | ERYTHROMYCIN |
| Application type | NDA |
| Application number | 050617 |
| Company | MYLAN |
| Dosage forms | GEL, TOPICAL |
| Strength | 2% |
| Marketing status | Discontinued |
| TE codes | AT |
| Reference listed drug | Yes |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Oct 21, 1987 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.